1 Min Read
Feb 6 (Reuters) - Endo International PLC:
* ENDO ANNOUNCES INITIATION OF TWO PIVOTAL PHASE 3 CLINICAL TRIALS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR THE TREATMENT OF CELLULITE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.